Changes in the proteomic profile during the differential polarization status of the human monocyte-derived macrophage THP-1 cell line

Proteomics

Volumn 15, Issue 4, 2015, Pages 773-786

  Zhang, Fan ^a   Liu, Hao ^b   Jiang, Guanmin ^c   Wang, Hongsheng ^a   Wang, Xianfeng ^d   Wang, Hao ^a   Fang, Rui ^a   Cai, Shaohui ^e   Du, Jun ^a  

^a SUN YAT SEN UNIVERSITY   (China)

^b GUANGZHOU MEDICAL UNIVERSITY   (China)

^c THE FIRST AFFILIATED HOSPITAL OF UNIVERSITY OF SOUTH CHINA   (China)

^d SHENZHEN CENTER FOR DISEASE CONTROL AND PREVENTION   (China)

^e JINAN UNIVERSITY   (China)

Author keywords

2DE; Cell biology; Inflammation; Macrophage polarization; Proteomic analysis; THP 1 cell

Indexed keywords

ANTIOXIDANT; GAMMA INTERFERON; HEAT SHOCK PROTEIN; LIPOPOLYSACCHARIDE; NITRIC OXIDE; REACTIVE OXYGEN METABOLITE; PROTEOME;

ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN CELL; MACROPHAGE; MONOCYTE; OXIDATIVE STRESS; POLARIZATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN METABOLISM; PROTEIN STRUCTURE; PROTEOMICS; STRESS; UPREGULATION; BIOLOGICAL MODEL; CELL LINE; CHEMISTRY; IMMUNOLOGY; PHENOTYPE; PHYSIOLOGY; TWO DIMENSIONAL GEL ELECTROPHORESIS;

CELL LINE; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; HUMANS; MACROPHAGES; MODELS, IMMUNOLOGICAL; PHENOTYPE; PROTEOME; PROTEOMICS;

EID: 84922896809     PISSN: 16159853     EISSN: 16159861     Source Type: Journal    
DOI: 10.1002/pmic.201300494     Document Type: Article

References (48)

1. Stein, M., Keshav, S., Harris, N., Gordon, S., Interleukin 4 potently enhances murine macrophage mannose receptor activity: a marker of alternative immunologic macrophage activation. J. Exp. Med. 1992, 176, 287-292.
2. Mantovani, A., Sozzani, S., Locati, M., Allavena, P., Sica, A., Macrophage polarization: tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes. Trends Immunol. 2002, 23, 549-555.
3. Mantovani, A., Sica, A., Sozzani, S., Allavena, P. et al., The chemokine system in diverse forms of macrophage activation and polarization. Trends Immunol. 2004, 25, 677-686.
4. Vats, D., Mukundan, L., Odegaard, J. I., Zhang, L. et al., Oxidative metabolism and PGC-1β attenuate macrophage-mediated inflammation. Cell Metab. 2006, 4, 13-24.
5. Biswas, S. K., Gangi, L., Paul, S., Schioppa, T. et al., A distinct and unique transcriptional program expressed by tumor-associated macrophages (defective NF-κB and enhanced IRF-3/STAT1 activation). Blood 2006, 107, 2112-2122.
6. Wang, X. F., Wang, H. S., Zhang, F., Guo, Q. et al., Nodal promotes the generation of M2-like macrophages and downregulates the expression of IL-12. Eur. J. Immunol. 2014, 44, 173-183.
7. Rabilloud, T., Adessi, C., Giraudel, A., Lunardi, J., Improvement of the solubilization of proteins in two-dimensional electrophoresis with immobilized pH gradients. Electrophoresis 1997, 18, 307-316.
8. Görg, A., Postel, W., Weser, J., Günther, S. et al., Elimination of point streaking on silver stained two-dimensional gels by addition of iodoacetamide to the equilibration buffer. Electrophoresis 1987, 8, 122-124.
9. Neuhoff, V., Arold, N., Taube, D., Ehrhardt, W., Improved staining of proteins in polyacrylamide gels including isoelectric focusing gels with clear background at nanogram sensitivity using Coomassie Brilliant Blue G-250 and R-250. Electrophoresis 1988, 9, 255-262.
10. Wang, H., Wang, H.-S., Zhou, B.-H., Li, C.-L. et al., Epithelial-mesenchymal transition (EMT) induced by TNF-α requires AKT/GSK-3β-mediated stabilization of snail in colorectal cancer. PLoS One 2013, 8, e56664.
11. Chiba, K., Kawakami, K., Tohyama, K., Simultaneous evaluation of cell viability by neutral red, MTT and crystal violet staining assays of the same cells. Toxicol. In Vitro 1998, 12, 251-258.
12. Porcheray, F., Viaud, S., Rimaniol, A. C., Leone, C. et al., Macrophage activation switching: an asset for the resolution of inflammation. Clin. Exp. Immunol. 2005, 142, 481-489.
13. Oh, G.-S., Pae, H.-O., Lee, B.-S., Kim, B.-N. et al., Hydrogen sulfide inhibits nitric oxide production and nuclear factor-κB via heme oxygenase-1 expression in RAW264. 7 macrophages stimulated with lipopolysaccharide. Free Radical Biol. Med. 2006, 41, 106-119.
14. Álvarez-Maqueda, M., El Bekay, R., Alba, G., Monteseirín, J. et al., 15-Deoxy-Δ12, 14-prostaglandin J2 induces heme oxygenase-1 gene expression in a reactive oxygen species-dependent manner in human lymphocytes. J. Biol. Chem. 2004, 279, 21929-21937.
15. Bussière, F. I., Chaturvedi, R., Cheng, Y., Gobert, A. P. et al., Spermine causes loss of innate immune response to Helicobacter pylori by inhibition of inducible nitric-oxide synthase translation. J. Biol. Chem. 2005, 280, 2409-2412.
16. Zhang, M., Caragine, T., Wang, H., Cohen, P. S. et al., Spermine inhibits proinflammatory cytokine synthesis in human mononuclear cells: a counterregulatory mechanism that restrains the immune response. J. Exp. Med. 1997, 185, 1759-1768.
17. Otterbein, L. E., Bach, F. H., Alam, J., Soares, M. et al., Carbon monoxide has anti-inflammatory effects involving the mitogen-activated protein kinase pathway. Nat. Med. 2000, 6, 422-428.
18. Barañano, D. E., Rao, M., Ferris, C. D., Snyder, S. H., Biliverdin reductase: a major physiologic cytoprotectant. Proc. Natl. Acad. Sci. 2002, 99, 16093-16098.
19. Yachie, A., Niida, Y., Wada, T., Igarashi, N. et al., Oxidative stress causes enhanced endothelial cell injury in human heme oxygenase-1 deficiency. J. Clin. Invest. 1999, 103, 129-135.
20. Poss, K. D., Tonegawa, S., Reduced stress defense in heme oxygenase 1-deficient cells. Proc. Natl. Acad. Sci. 1997, 94, 10925-10930.
21. Morse, D., Choi, A. M., Heme oxygenase-1: the "emerging molecule" has arrived. Am. J. Resp. Cell. Mol. 2002, 27, 8-16.
22. Minamoto, K., Harada, H., Lama, V. N., Fedarau, M. A., Pinsky, D. J., Reciprocal regulation of airway rejection by the inducible gas-forming enzymes heme oxygenase and nitric oxide synthase. J. Exp. Med. 2005, 202, 283-294.
23. Srisook, K., Cha, Y.-N., Super-induction of HO-1 in macrophages stimulated with lipopolysaccharide by prior depletion of glutathione decreases iNOS expression and NO production. Nitric Oxide 2005, 12, 70-79.
24. Otterbein, L. E., Soares, M. P., Yamashita, K., Bach, F. H., Heme oxygenase-1: unleashing the protective properties of heme. Trends Immunol. 2003, 24, 449-455.
25. Lin, H.-Y., Juan, S.-H., Shen, S.-C., Hsu, F.-L., Chen, Y.-C., Inhibition of lipopolysaccharide-induced nitric oxide production by flavonoids in RAW264. 7 macrophages involves heme oxygenase-1. Biochem. Pharmacol. 2003, 66, 1821-1832.
26. Yang, N.-C., Lu, L.-H., Kao, Y.-H., Heme oxygenase-1 attenuates interleukin-1β-induced nitric oxide synthase expression in vascular smooth muscle cells. J. Biomed. Sci. 2004, 11, 799-809.
27. Seiler, N., Atanassov, C., Progress in Drug Research/Fortschritte der Arzneimittelforschung/Progrès des recherches pharmaceutiques, Birkhäuser Verlag, Basel 1994, pp. 87-141.
28. Szabo, C., Southan, G. J., Thiemermann, C., Vane, J. R., The mechanism of the inhibitory effect of polyamines on the induction of nitric oxide synthase: role of aldehyde metabolites. Brit. J. Pharmacol. 1994, 113, 757-766.
29. Pockley, A. G., Heat shock proteins as regulators of the immune response. Lancet 2003, 362, 469-476.
30. Cuellar, A., Santander, S. P., del Carmen Thomas, M., Guzmán, F. et al., Monocyte-derived dendritic cells from chagasic patients vs healthy donors secrete differential levels of IL-10 and IL-12 when stimulated with a protein fragment of Trypanosoma cruzi heat-shock protein-70. Immunol. Cell Biol. 2008, 86, 255-260.
31. Noessner, E., Gastpar, R., Milani, V., Brandl, A. et al., Tumor-derived heat shock protein 70 peptide complexes are cross-presented by human dendritic cells. J. Immunol. 2002, 169, 5424-5432.
32. Pereira, S. R., Faça, V. M., Gomes, G. G., Chammas, R. et al., Changes in the proteomic profile during differentiation and maturation of human monocyte-derived dendritic cells stimulated with granulocyte macrophage colony stimulating factor/interleukin-4 and lipopolysaccharide. Proteomics 2005, 5, 1186-1198.
33. Ferret-Bernard, S., Curwen, R. S., Mountford, A. P., Proteomic profiling reveals that Th2-inducing dendritic cells stimulated with helminth antigens have a 'limited maturation' phenotype. Proteomics 2008, 8, 980-993.
34. Le Naour, F., Hohenkirk, L., Grolleau, A., Misek, D. E. et al., Profiling changes in gene expression during differentiation and maturation of monocyte-derived dendritic cells using both oligonucleotide microarrays and proteomics. J. Biol. Chem. 2001, 276, 17920-17931.
35. Adra, C. N., Ko, J., Leonard, D., Wirth, L. J. et al., Identification of a novel protein with GDP dissociation inhibitor activity for the ras-like proteins CDC42Hs and Rac 1. Genes, Chromosomes Cancer 1993, 8, 253-261.
36. Kang, J. H., Kim, H. T., Choi, M. S., Lee, W. H. et al., Proteome analysis of human monocytic THP-1 cells primed with oxidized low-density lipoproteins. Proteomics 2006, 6, 1261-1273.
37. Kobayashi, M., Azuma, E., Ido, M., Hirayama, M. et al., A pivotal role of Rho GTPase in the regulation of morphology and function of dendritic cells. J. Immunol. 2001, 167, 3585-3591.
38. DerMardirossian, C., Bokoch, G. M., GDIs: central regulatory molecules in Rho GTPase activation. Trends Cell Biol. 2005, 15, 356-363.
39. Nijtmans, L. G., de Jong, L., Sanz, M. A., Coates, P. J. et al., Prohibitins act as a membrane-bound chaperone for the stabilization of mitochondrial proteins. EMBO J. 2000, 19, 2444-2451.
40. Mishra, S., Murphy, L. C., Nyomba, B., Murphy, L. J., Prohibitin: a potential target for new therapeutics. Trends Mol. Med. 2005, 11, 192-197.
41. Wang, S., Fusaro, G., Padmanabhan, J., Chellappan, S. P., Prohibitin co-localizes with Rb in the nucleus and recruits N-CoR and HDAC1 for transcriptional repression. Oncogene 2002, 21, 8388-8396.
42. Sandhu, J. K., Robertson, S., Birnboim, H. C., Goldstein, R., Distribution of protein nitrotyrosine in synovial tissues of patients with rheumatoid arthritis and osteoarthritis. J. Rheumatol. 2003, 30, 1173-1181.
43. Molavi, B., Mehta, J. L., Oxidative stress in cardiovascular disease: molecular basis of its deleterious effects, its detection, and therapeutic considerations. Curr. Opin. Cardiol. 2004, 19, 488-493.
44. Theiss, A. L., Idell, R. D., Srinivasan, S., Klapproth, J.-M. et al., Prohibitin protects against oxidative stress in intestinal epithelial cells. FASEB J. 2007, 21, 197-206.
45. Theiss, A. L., Sitaraman, S. V., The role and therapeutic potential of prohibitin in disease. Biochim. Biophys. Acta 2011, 1813, 1137-1143.
46. Theiss, A. L., Jenkins, A. K., Okoro, N. I., Klapproth, J.-M. A. et al., Prohibitin inhibits tumor necrosis factor alpha-induced nuclear factor-kappa b nuclear translocation via the novel mechanism of decreasing importin α3 expression. Molecular biology of the cell 2009, 20, 4412-4423.
47. Theiss, A. L., Vijay-Kumar, M., Obertone, T. S., Jones, D. P. et al., Prohibitin is a novel regulator of antioxidant response that attenuates colonic inflammation in mice. Gastroenterology 2009, 137, 199-208. e196.
48. Theiss, A. L., Laroui, H., Obertone, T. S., Chowdhury, I. et al., Nanoparticle-based therapeutic delivery of prohibitin to the colonic epithelial cells ameliorates acute murine colitis. Inflamm. Bowel Dis. 2011, 17, 1163-1176.